All Comments by Benjamin Wolozin

  1. Cholinesterase inhibitors: expanding applications.
  2. Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway.
  3. Endogenous beta-amyloid production in presenilin-deficient embryonic mouse fibroblasts.
  4. Determinants of 4-repeat tau expression. Coordination between enhancing and inhibitory splicing sequences for exon 10 inclusion.
  5. p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction.
  6. Staging of neurofibrillary degeneration caused by human tau overexpression in a unique cellular model of human tauopathy.
  7. The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner.
  8. Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17.
  9. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease.
  10. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.
  11. Beta-secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain.
  12. Fe65 and X11beta co-localize with and compete for binding to the amyloid precursor protein.
  13. Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains.
  14. The effects of nicotine on Parkinson's disease.
  15. Tau-66: evidence for a novel tau conformation in Alzheimer's disease.